Trial Profile
Randomized, double-blind study for the evaluation of the effect of losartan versus placebo on aortic root dilatation in patients with Marfan syndrome under treatment with beta-blockers.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 15 Jun 2015
Price :
$35
*
At a glance
- Drugs Losartan (Primary)
- Indications Aortic disorders; Marfan syndrome
- Focus Therapeutic Use
- 12 Sep 2014 New trial record